What Is a Good Fetal Fraction? And Why It Matters

A fetal fraction of at least 4% is widely considered the minimum needed for a reliable result on non-invasive prenatal testing (NIPT), though most pregnancies produce fractions well above that threshold. The term refers to the proportion of cell-free DNA in your blood that comes from the placenta (and therefore represents the fetus) rather than from your own cells. When that proportion is too low, the lab cannot confidently distinguish a normal result from an abnormal one, and you may get a “no-call” or non-reportable result instead of an answer. But the story is more nuanced than a single cutoff number, because fetal fraction is shaped by your body, your pregnancy, when you get tested, and even what medications you take.

The 4% Threshold and What It Actually Means

Most commercial NIPT platforms set their reporting cutoff somewhere around 4% fetal fraction. Below that level, the test does not have enough placental DNA to reliably detect extra or missing chromosomes. One study examining samples that failed NIPT because of fetal fractions below 4% found that the rate of trisomy among those failures was not dramatically different from the rate among samples above the cutoff, which tells you the cutoff exists for sensitivity reasons rather than because low fetal fraction automatically signals a problem.¹ A minimum fetal fraction is required for reliable test performance, and the accuracy of the method used to measure it matters too.²

That said, higher is genuinely better. Research using a PCR-free, low-depth whole-genome sequencing method found that a fetal fraction of at least 5% was needed for 100% detection of trisomy 21 (Down syndrome).³ For rarer conditions like trisomy 13 and trisomy 18, the detection challenge is even steeper at borderline fetal fractions, because fewer placental DNA fragments carry the signal the test is looking for. In practice, most women tested between 10 and 20 weeks of pregnancy have fetal fractions somewhere in the range of 10–15%, so the 4% floor is comfortably cleared in the vast majority of cases.

Why Gestational Age Matters

Fetal fraction rises as pregnancy progresses, but not in a perfectly smooth line. Between roughly 10 and 21 weeks, the increase is modest, around 0.1 percentage points per week.⁴ After 21 weeks, the rise accelerates to about 1 percentage point per week. This is why NIPT is typically offered starting at 10 weeks of gestation: before that, fetal fraction tends to be too low for a confident result.

Testing earlier than 10 weeks is associated with higher no-call rates. A recent study confirmed that samples collected at 10 weeks or later had meaningfully higher fetal fractions than those collected before 10 weeks, even after adjusting for maternal age and BMI.⁵ There is also an interesting wrinkle: one analysis found that fetal fraction does not climb in a perfectly steady way through the first and second trimesters, with a temporary dip around 15 weeks of gestation.⁶ The clinical significance of that dip is still being studied, but it is a reminder that fetal fraction is not a simple “more weeks equals more DNA” situation.

How Body Weight Affects Fetal Fraction

Maternal weight is one of the strongest predictors of fetal fraction, and it works in a direction that catches some people off guard. Higher BMI is consistently linked to lower fetal fraction. The mechanism is not that the placenta releases less DNA in heavier women. Instead, women with higher BMI tend to have more maternal cell-free DNA in circulation, which dilutes the placental contribution. One study found a clear negative relationship between BMI and fetal fraction while showing no relationship at all between BMI and total cell-free DNA concentration.⁷ It is the ratio that shifts, not the absolute amount of fetal DNA.

The practical consequence is a higher rate of test failures. Compared to women with a normal BMI, those with a BMI of 35 or above saw fetal fraction increase at roughly a third the rate per week of gestation, and both no-call rates and outright failure rates were higher.⁸ This does not mean NIPT is off the table if your BMI is elevated. It does mean that testing slightly later in pregnancy, or being prepared for the possibility of a redraw, can help improve the odds of getting a reportable result.

Medications That Can Lower Fetal Fraction

If you are on blood thinners, your NIPT result may be affected. Anticoagulants like heparin have a striking association with lower fetal fractions and higher rates of non-reportable results. In one study, women on anticoagulation had an average fetal fraction of about 9% compared to nearly 12% in women not on blood thinners, and their rate of indeterminate results jumped from under 3% to over 17%.⁹ After adjusting for BMI and gestational age, anticoagulation was linked to more than an eightfold increase in the likelihood of an indeterminate result.

Aspirin alone appears to have a milder effect. The same study found that fetal fraction was slightly lower in aspirin users, but the rate of indeterminate results was not significantly different from the general population. A separate retrospective cohort study, however, found that both heparin and aspirin were associated with increased rates of non-reportable NIPT results in a multivariate analysis, with heparin carrying a much larger effect.¹⁰ That study also flagged chronic hypertension and autoimmune disease as independent contributors to non-reportable results. If you are on heparin or a similar anticoagulant for medical reasons, your provider may want to time the blood draw strategically or discuss diagnostic alternatives.

What Low Fetal Fraction Can Signal Beyond a Bad Blood Draw

A low fetal fraction is sometimes just a quirk of timing, weight, or sample handling. But it can also be a flag for something clinically important. A large systematic review and meta-analysis found that low fetal fraction was associated with a roughly sixfold higher risk of trisomy 13, a roughly fourfold higher risk of trisomy 18, a roughly sixfold higher risk of monosomy X, and a dramatically higher risk of triploidy, compared to pregnancies with normal fetal fraction.¹¹ Interestingly, the association did not hold for trisomy 21, which is the most common of these conditions. This likely reflects the fact that placentas carrying certain chromosomal abnormalities produce less cell-free DNA, while trisomy 21 placentas function more normally in this respect.

A study of pregnancies with fetal fractions below a reporting threshold found that confirmed chromosomal abnormalities occurred at a rate significantly higher than what would be expected based on maternal age and gestational age alone. Triploidy was particularly overrepresented, occurring at roughly 90 times the expected rate.¹² This is why a “no result” on NIPT should not be treated as a “no news is good news” situation. Clinical guidelines generally recommend that women with failed NIPT due to low fetal fraction be offered genetic counseling and possibly diagnostic testing such as amniocentesis.

Pregnancies with NIPT failures are also at heightened risk for placenta-mediated complications, not just chromosomal abnormalities.¹³ The placenta is the source of the fetal cell-free DNA being measured, so a poorly functioning placenta can produce less DNA. This connection to placental health is why some researchers have explored whether fetal fraction itself might serve as a marker for pregnancy complications. One study found that women with very high fetal fractions at 14 to 20 weeks had an elevated risk of preterm birth, suggesting that extreme values in either direction warrant attention.¹⁴

What Happens if You Get a No-Call Result

When your NIPT comes back as non-reportable or indeterminate, the most common next step is a repeat blood draw. Whether that second attempt succeeds depends on a few factors. The likelihood of getting a usable result on a redraw is significantly influenced by your initial fetal fraction, your weight, and how much time passes between the two blood draws.¹⁵ If your first fetal fraction was only slightly below the cutoff, waiting a couple of weeks and trying again often works. If it was very low and you have other risk factors like high BMI or early gestational age, your provider may recommend going directly to diagnostic testing instead of burning time on a second screen.

Some labs now use fetal-fraction-based risk algorithms that can extract useful information even from samples that fall below the standard reporting threshold. These algorithms factor in how far below the cutoff the fetal fraction was, alongside the chromosomal signal data, to generate a risk estimate that may still be clinically useful for certain conditions. This is an evolving area, and not all NIPT platforms offer this capability.

Twin Pregnancies and Fetal Fraction

NIPT in twin pregnancies adds a layer of complexity. In identical (monozygotic) twins, both babies share the same DNA, so the test works much like it does in a singleton pregnancy, with a combined fetal fraction from one shared placenta. In fraternal (dizygotic) twins, each fetus has its own placenta contributing its own cell-free DNA, and the total fetal fraction is split unevenly between the two. The test’s accuracy depends on having enough DNA from the twin with the lower contribution.¹⁶

In one study, the median smallest fetal fraction contribution in dizygotic twins was about 8%, compared to a median total fetal fraction of 14% in monozygotic twins.¹⁷ The fact that the “weaker” twin in a fraternal pair may hover near the reporting threshold means that twin pregnancies face a somewhat higher risk of inconclusive NIPT results. Some platforms now measure each twin’s individual fetal fraction in dizygotic pregnancies rather than just the combined total, which improves confidence that neither twin’s DNA is being overlooked.

Sample Handling and Storage

Before your blood even reaches the lab’s sequencer, how the sample is handled can influence fetal fraction. The amount of fetal DNA in a blood sample stays relatively stable across a wide range of storage temperatures. But if the sample is stored at room temperature or above for extended periods, maternal white blood cells begin to break down and release their own genomic DNA into the plasma, diluting the fetal fraction. Research has shown that fetal DNA quantity held steady across storage temperatures from 4°C to 40°C, but the total (mostly maternal) DNA increased at 23°C and above.¹⁸ This is why NIPT blood draws use specialized collection tubes containing preservatives that stabilize white blood cells and why labs have strict shipping protocols. If your draw happens at a clinic far from the processing lab, the quality of sample transport is a real, if often invisible, factor in your result.

False negative results, where NIPT misses a real chromosomal abnormality, can also be related to low fetal fraction caused by suboptimal sample storage, as well as testing too early in pregnancy or high maternal BMI.¹⁹ The presence of a vanishing twin with normal chromosomes can also confuse results by contributing euploid DNA that masks an abnormality in the surviving twin.

How Fragment Size Plays a Role

The cell-free DNA in your blood comes in fragments of varying lengths. Fetal fragments tend to be shorter than maternal fragments, and this size difference is actually exploited by some NIPT platforms to improve detection. A study analyzing over 1,400 pregnancies found that shorter DNA fragments were associated with substantially higher fetal fractions. Compared to the shortest fragments (120 base pairs or fewer), fragments in the 131–140 base pair range showed a fetal fraction that was about 9.5 percentage points lower, and those 141 base pairs or longer showed a drop of about 14.5 points.²⁰ Some newer sequencing approaches selectively analyze shorter fragments to boost the effective fetal fraction, which could help rescue samples that would otherwise fall below the reporting cutoff.

When NIPT Accidentally Finds Something Else

Because NIPT sequences all the cell-free DNA in your blood, not just the fetal portion, it occasionally picks up signals that have nothing to do with the baby. In rare cases, unusual patterns in cell-free DNA, sometimes accompanied by low or non-reportable fetal fractions, have led to the incidental discovery of a previously undiagnosed maternal cancer. Tumor cells shed DNA into the bloodstream just as the placenta does, and that tumor DNA can create confusing patterns that the NIPT algorithm was not designed to interpret.²¹ In one reported case, an initial NIPT at 11 weeks was non-reportable due to insufficient fetal fraction, and a repeat test at 16 weeks flagged an atypical finding of maternal origin. These situations are uncommon, but they underscore that a failed or unusual NIPT result deserves careful clinical follow-up rather than a shrug.

Fetal Y-chromosome abnormalities represent another source of confusion. In pregnancies carrying a male fetus with certain Y-chromosome anomalies, the algorithms that estimate fetal fraction using Y-chromosome reads can produce falsely low values, potentially triggering a no-call result when the true fetal fraction is actually adequate. Researchers have proposed combining standard fetal-fraction estimation methods with Y-chromosome read distribution analysis to catch these cases before reporting a test failure.²²

How Quickly Fetal DNA Clears After Delivery

If you are wondering whether leftover fetal DNA from a previous pregnancy could interfere with NIPT in a new one, the answer is almost certainly no. Fetal cell-free DNA is cleared from the maternal circulation rapidly after delivery. Early research tracking Y-chromosome sequences in women who delivered boys found that no fetal DNA was detectable by eight weeks postpartum.²³ A more detailed study found that clearance was complete within two weeks in all women tested, regardless of whether labor was spontaneous or induced.²⁴ Given that NIPT is performed at 10 weeks or later in the next pregnancy, there is no realistic scenario in which DNA from a previous baby is still circulating. The same research confirmed that fetal DNA is identifiable in maternal blood as early as seven weeks of gestation, so the system ramps up quickly with each new pregnancy.